These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18989266)

  • 1. China takes first steps toward healthcare and drug reforms.
    Hughes V
    Nat Med; 2008 Nov; 14(11):1132. PubMed ID: 18989266
    [No Abstract]   [Full Text] [Related]  

  • 2. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
    Stephan K
    Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
    [No Abstract]   [Full Text] [Related]  

  • 3. Bad execution.
    Nature; 2007 Jun; 447(7145):613-4. PubMed ID: 17554265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Soviet synopsis--Part II: the Soviet system of healthcare delivery and pharmaceutical distribution.
    Griffis K; Hightower WL; Roberts KB
    Med Mark Media; 1980 Oct; 15(10):72-5, 78-80. PubMed ID: 10317026
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug scheduling--science and cultural perspective.
    Ray R; Dhawan A
    Addiction; 2010 Jul; 105(7):1151-3. PubMed ID: 20642501
    [No Abstract]   [Full Text] [Related]  

  • 7. China cracks down on counterfeiters.
    Mooney P
    Nat Med; 2010 Apr; 16(4):360. PubMed ID: 20376025
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Designer Drug' Enforcement Act seeks to attack problem at source.
    Hagerty C
    Am Pharm; 1985 Oct; NS25(10):10-1. PubMed ID: 4061277
    [No Abstract]   [Full Text] [Related]  

  • 9. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality].
    Prugnaud JL
    Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed consent--a new approach to drug regulation?
    Nutt DJ
    J Psychopharmacol; 2006 Jan; 20(1):3-4. PubMed ID: 16354734
    [No Abstract]   [Full Text] [Related]  

  • 11. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethnic variation in drug response: implications for the development and regulation of drugs.
    Johnson DE; Park BK; Smith DA
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):29-31. PubMed ID: 18175264
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care overseas: Chinese revolutions.
    Nurs Times; 1989 Jul 19-25; 85(29):49-50. PubMed ID: 2771720
    [No Abstract]   [Full Text] [Related]  

  • 14. Simon Stevens on China's plans for healthcare.
    Stevens S
    Health Serv J; 2008 Jun; ():17. PubMed ID: 18637247
    [No Abstract]   [Full Text] [Related]  

  • 15. China's health system and its reform: a review of recent studies.
    Wagstaff A; Yip W; Lindelow M; Hsiao WC
    Health Econ; 2009 Jul; 18 Suppl 2():S7-23. PubMed ID: 19551753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tensions between approach paradigms in public policies on drugs: an analysis of Brazilian legislation in 2000-2016.
    Teixeira MB; Ramôa ML; Engstrom E; Ribeiro JM
    Cien Saude Colet; 2017 May; 22(5):1455-1466. PubMed ID: 28538917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the changing health care environment on drug innovation and marketing.
    Flanagan AD
    Ann N Y Acad Sci; 1981; 368():171-4. PubMed ID: 6942775
    [No Abstract]   [Full Text] [Related]  

  • 18. Contempo '81. Trends in regulation and development of new drugs.
    Ballin JC
    JAMA; 1981 Jun; 245(21):2161-3. PubMed ID: 7230409
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic analysis of China's health care system: turning a new page.
    Yip W; Wagstaff A; Hsiao WC
    Health Econ; 2009 Jul; 18 Suppl 2():S3-6. PubMed ID: 19551754
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging trends in Chinese healthcare: the impact of a rising middle class.
    Chang J; Wood D; Xiaofeng J; Gifford B
    World Hosp Health Serv; 2008; 44(4):11-20. PubMed ID: 19370831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.